To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone
Diagnosis of central serous chorioretinopathy (CSC) with no response to conservative therapy, consisted in Acetazolamide and Eplerenone after six months.
Foveal serous retinal detachment for at least 6 months.
Minimum age of 18 years old at the screening time
Reading and comprehension skills of informed consent
Previous retinal treatment for CSC, except for Acetazolamide and Eplerenone
No diffuse retinal epitheliopathy
Other concomitant ocular diseases, such as age related macular degeneration, diabetic retinopathy, choroidal neovascularization
Not controlled glaucoma with eyedrops, or advanced glaucoma